DETAILED PROJECT REPORT

1. Introduction
2. Overview
3. Impact Of Covid-19 On Pharmaceutical
4. Innovation
4.1 Strengthening India’s Research And Innovation Ecosystem
4.2 Government Support – Policy And Regulations
5. Research and Development
6. Spending on Pharma Medicines
7. Indian Pharmaceutical Industry
7.1 Indian pharma industry: current scenario and future potential
7.2 Indian pharma industry landscape
7.3 Export market
7.4 Domestic market
7.5 Opportunities For the Indian Pharma Industry to Move Up The Value Chain.
7.6 Opportunities To Improve Manufacturing And Supply Chain
7.7 Opportunities That Beckon Indian Pharma Industry
7.8 Establish India as The Global Innovation Hub
7.9 Key Challenges Faced By Manufacturing And Supply Chain
7.10 Need to explore new ways of improving access to medicines
8. Research opportunity
8.1 Contract research opportunity
8.2 Key challenges in achieving research and innovation potential
9. Complex regulatory approval process and Intellectual Property Regime (IPR)
9.1 Intellectual property (IP) regime in India
9.2 Drug regulatory system
10. Indian Drugs Market Analysis
10.1 Introduction
10.2 Market Drivers
10.3 Oncology Drugs Market Overview
10.4 Segmental review
11. Medicine Manufacturers in India
12. Guide To Good Manufacturing Practice for Pharmaceutical Products
12.1 Pharmaceutical Quality System
12.2 Personnel
12.3 Premises And Equipment
12.4 Documentation
12.5 Production
12.6 Quality Control
12.7 Outsourced Activities
12.8 Complaints And Product Recall
13. Our Products
13.1 Their raw material
14. Manufacturing Process
14.1 Detailed Process Flow – Tablet
14.2 Detailed Process Flow – Capsules
14.3 Detailed Process Flow – Injection
15. SWOT Analysis
16. Annexures
16.1 Content
16.2 Cost of Project
16.3 Machinery
16.4 Preliminary Expenses
16.5 Assumptions
16.6 Raw Material
16.7 Debt Schedule
16.8 Manpower
16.9 Power & fuel
16.10 Depreciation
16.11 Profitability
16.12 Working Capital Assessment
16.13 Break Even Point
16.14 Internal Rate of Return
16.15 Interest Service Coverage Ratio
16.16 Financial Summary
16.17 Tax calculation
16.18 Balance Sheet & Fund Flow